The highly neuroinflammatory disease caused by herpes zoster (HZ ... He’ll examine Shingrix's real-world effectiveness in preventing HZ infection while estimating the vaccine’s effectiveness in ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit ...

It is recommended that adults 50 and older receive two doses of Shingrix, the shingles vaccine, two to six months apart, per the CDC. The vaccine protects against a condition called herpes zoster ...

Varicella-zoster virus causes chickenpox and is a member of the herpes virus group. It is extremely contagious and causes a ...

These two reports address the effects of varicella-zoster vaccination and varicella vaccination ... The incidence of herpes zoster was 5.4 cases vs. 11.1 cases per 1000 person-years in the ...

Finally, it’s too late for your mother, but older people who have not had the newer two-dose shingles vaccine (Shingrix) ...

Amezosvatein and Shingrix are adjuvanted recombinant protein subunit ... "Effectiveness of a recombinant zoster vaccine against herpes zoster in a real-world-setting.” Annals of Internal Medicine, ...

adjuvanted subunit vaccine also known as CRV-101) head-to-head versus Shingrix® in participants aged 50 years and older. There were zero confirmed cases of herpes zoster (shingles) in the ...